Hansoh Pharmaceutical Group Co Ltd (3692)

Hong Kong
17.88
-0.44(-2.40%)
  • Volume:
    1,828,843
  • Bid/Ask:
    17.86/17.92
  • Day's Range:
    17.80 - 19.50

3692 Overview

Prev. Close
18.32
Day's Range
17.8-19.5
Revenue
11.17B
Open
19.5
52 wk Range
15.56-46.7
EPS
0.54
Volume
1,828,843
Market Cap
108.5B
Dividend (Yield)
0.08
(0.42%)
Average Volume (3m)
4,000,882
P/E Ratio
33.71
Beta
-
1-Year Change
-57.98%
Shares Outstanding
5,922,350,070
Next Earnings Date
-
What is your sentiment on Hansoh Pharmaceutical Group Co Ltd?
or
Market is currently closed. Voting is open during market hours.

Hansoh Pharmaceutical Group Co Ltd Company Profile

Employees
12030
Market
Hong Kong

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the People’s Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, diabetes, and cardiovascular, as well as gastrointestinal area. Its principal products include Mailingda, a category 1.1 drug for the treatment of chronic myelogenous leukemia; and Ameile, Hansoh Xinfu, Pulaile, Zefei, Xinwei, Xinmei, Xintai, Tanneng, Afatinib Dimaleate, Sunitinib Malate, Oulanning, Ameining, Ailanning, Zetan, Hengjie, Hengsen, Fulaimei, Fulaidi, Fulairui, Ruibote, Zexin, Ruiyisheng, Empagliflozin, and Saxagliptin, which are generic drugs. The company serves pharmaceutical product distributors. It has a strategic collaboration with Viela Bio, Inc. to develop and commercialize inebilizumab for the treatment of autoimmune diseases and hematologic cancers; and strategic collaboration and license agreement with EQRx, INC. to research, develop, manufacture, and commercialize Almonertinib. The company also has a collaboration with Silence Therapeutics plc to develop siRNAs for three undisclosed targets leveraging Silence’s mRNAi GOLD platform. The company was founded in 1995 and is headquartered in Lianyungang, the People’s Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsNeutralStrong SellStrong SellNeutralStrong Sell
SummaryNeutralStrong SellStrong SellSellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.